4.7 Article

Effects of 1-methyl-1, 2, 3, 4-tetrahydroisoquinoline on a diabetic neuropathic pain model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Endocrinology & Metabolism

IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045

Hong Sun et al.

Summary: This study provides global, regional, and country-level estimates of diabetes prevalence and health expenditures for 2021 and projections for 2045. The global prevalence of diabetes is increasing and is expected to have the greatest relative increase in middle-income countries. Diabetes-related health expenditures are also projected to rise.

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Article Pharmacology & Pharmacy

Cilostazol Ameliorates Peripheral Neuropathic Pain in Streptozotocin-Induced Type I Diabetic Rats

Kuang-I. Cheng et al.

Summary: Oral cilostazol can attenuate the responses of mechanical allodynia and has the potential to treat diabetic neuropathy by attenuating NaV and glial cell dysregulation.

FRONTIERS IN PHARMACOLOGY (2022)

Article Endocrinology & Metabolism

Screening, diagnosis and management of diabetic sensorimotor polyneuropathy in clinical practice: International expert consensus recommendations

Dan Ziegler et al.

Summary: Diabetic sensorimotor polyneuropathy (DSPN) is a common condition in diabetes patients, affecting around one third of them. It can lead to various complications and has significant impact on patients' lives. However, it is often inadequately diagnosed and treated. This article provides expert consensus recommendations and algorithms for the screening, diagnosis, and treatment of DSPN, aiming to improve patients' quality of life.

DIABETES RESEARCH AND CLINICAL PRACTICE (2022)

Review Pediatrics

The development of descending serotonergic modulation of the spinal nociceptive network: a life span perspective

Anne R. de Kort et al.

Summary: The nociceptive network is not fully developed at birth and descending serotonergic modulation switches from facilitation in early life to bimodal control in adulthood. A functional inhibitory serotonergic system already exists in the neonatal phase but is masked by descending facilitation.

PEDIATRIC RESEARCH (2022)

Review Pharmacology & Pharmacy

Neuroinflammation Involved in Diabetes-Related Pain and Itch

Xiao-Xia Fang et al.

Summary: Diabetic neuropathy is a common chronic complication of diabetes mellitus, characterized by neuropathic pain and chronic itch. Neuroinflammation is believed to play a critical role in the pathophysiology of these symptoms, involving glial cells and pro-inflammatory mediators. Targeting neuroinflammation may offer potential therapies for the treatment of chronic neuropathic pain and itch in diabetes.

FRONTIERS IN PHARMACOLOGY (2022)

Review Pharmacology & Pharmacy

Preclinical Neuropathic Pain Assessment; the Importance of Translatability and Bidirectional Research

Amy S. Fisher et al.

Summary: The key to developing new analgesic treatments for neuropathic pain lies in the development of clinically relevant endpoints that can translate preclinical animal results to human clinical trials.

FRONTIERS IN PHARMACOLOGY (2021)

Review Biochemistry & Molecular Biology

Treatment of Painful Diabetic Neuropathy-A Narrative Review of Pharmacological and Interventional Approaches

Mayank Gupta et al.

Summary: Painful diabetic neuropathy (PDN) is a common complication of diabetes mellitus that significantly impacts quality of life. Various pharmacological options such as anticonvulsants, antidepressants, and topical capsaicin, as well as the recently approved tapentadol, are recommended for managing PDN. In addition to pharmacotherapy, neuromodulation therapies such as intrathecal therapy, TENS, and SCS have shown success in providing pain relief for PDN patients.

BIOMEDICINES (2021)

Review Pharmacology & Pharmacy

Vortioxetine as a new frontier in the treatment of chronic neuropathic pain: a review and update

Daniela Adamo et al.

Summary: CNP is a disabling medical condition with high prevalence of anxiety and depression. VO, a novel multimodal serotonergic antidepressant, has demonstrated efficacy in pain hypersensitivity and mood disorders in clinical studies, showing advantages over other antidepressants.

THERAPEUTIC ADVANCES IN PSYCHOPHARMACOLOGY (2021)

Review Neurosciences

The Mesolimbic Dopamine System in Chronic Pain and Associated Affective Comorbidities

Randal A. Serafini et al.

BIOLOGICAL PSYCHIATRY (2020)

Article Clinical Neurology

Diabetes Causes Dysfunctional Dopamine Neurotransmission Favoring Nigrostriatal Degeneration in Mice

Iara Perez-Taboada et al.

MOVEMENT DISORDERS (2020)

Article Chemistry, Medicinal

Analgesic and Antiallodynic Effects of 4-Fluoro-N-(4-Sulfamoylbenzyl) Benzene Sulfonamide in a Murine Model of Pain

Naeem Ur Rehman et al.

DRUG DESIGN DEVELOPMENT AND THERAPY (2020)

Review Neurosciences

Role of the Prefrontal Cortex in Pain Processing

Wei-Yi Ong et al.

MOLECULAR NEUROBIOLOGY (2019)

Review Endocrinology & Metabolism

Painful and Painless Diabetic Neuropathies: What Is the Difference?

Pallai Shillo et al.

CURRENT DIABETES REPORTS (2019)

Article Medicine, General & Internal

Diabetic neuropathy

Eva L. Feldman et al.

NATURE REVIEWS DISEASE PRIMERS (2019)

Article Clinical Neurology

Neuropathic pain's biopsychosocial effects

Esra Dogru Huzmeli et al.

NEUROLOGICAL SCIENCES (2017)

Review Pharmacology & Pharmacy

The mechanism of neuroprotective action of natural compounds

Agnieszka Wasik et al.

PHARMACOLOGICAL REPORTS (2017)

Review Neurosciences

Methods Used to Evaluate Pain Behaviors in Rodents

Jennifer R. Deuis et al.

FRONTIERS IN MOLECULAR NEUROSCIENCE (2017)

Article Clinical Neurology

Spinal 5-HT3 receptor mediates nociceptive effect on central neuropathic pain; possible therapeutic role for tropisetron

Farinaz Nasirinezhad et al.

JOURNAL OF SPINAL CORD MEDICINE (2016)

Article Integrative & Complementary Medicine

Passiflora incarnata attenuation of neuropathic allodynia and vulvodynia apropos GABA-ergic and opioidergic antinociceptive and behavioural mechanisms

Urooj Aman et al.

BMC COMPLEMENTARY AND ALTERNATIVE MEDICINE (2016)

Review Neurosciences

MODULATION OF PAIN, NOCICEPTION, AND ANALGESIA BY THE BRAIN REWARD CENTER

Vasiliki Mitsi et al.

NEUROSCIENCE (2016)

Article Pharmacology & Pharmacy

Antinociceptive effect of certain dimethoxy flavones in mice

Kamalakannan Pandurangan et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2014)

Article Endocrinology & Metabolism

Painful diabetic peripheral neuropathy: consensus recommendations on diagnosis, assessment and management

S. Tesfaye et al.

DIABETES-METABOLISM RESEARCH AND REVIEWS (2011)

Review Clinical Neurology

Preclinical and Early Clinical Investigations Related to Monoaminergic Pain Modulation

Kirsty Bannister et al.

NEUROTHERAPEUTICS (2009)

Review Clinical Neurology

Diabetic neuropathy - a review

Gerard Said

NATURE CLINICAL PRACTICE NEUROLOGY (2007)

Review Neurosciences

Noradrenergic pain modulation

Antti Pertovaara

PROGRESS IN NEUROBIOLOGY (2006)

Article Multidisciplinary Sciences

Estrogens protect pancreatic β-cells from apoptosis and prevent insulin-deficient diabetes mellitus in mice

Cedric Le May et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)

Review Pharmacology & Pharmacy

Synthesis and neurotoxicity of tetrahydroisoquinoline derivatives for studying Parkinson's disease

K Abe et al.

BIOLOGICAL & PHARMACEUTICAL BULLETIN (2005)

Review Pharmacology & Pharmacy

Antidepressants in the treatment of neuropathic pain

SH Sindrup et al.

BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2005)

Review Pharmacology & Pharmacy

Striatal dopamine D2 receptors in modulation of pain in humans:: a review

N Hagelberg et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2004)

Article Pharmacology & Pharmacy

1-Methyl-1,2,3,4-tetrahydroisoquinoline protects against rotenone-induced mortality and biochemical changes in rat brain

L Antkiewicz-Michaluk et al.

EUROPEAN JOURNAL OF PHARMACOLOGY (2003)